Abstract Products derived from the plant Cannabis sativa are widely appreciated for their analgesic properties and are employed for the treatment of chronic neuropathic pain.
Cannabis has a variety of effects that we can benefit from, even if we would not consider ourselves of the stoner variety.
European Molecular Biology Laboratory (EMBL), Grenoble, France, researchers have investigated the interaction between D9-tetrahydrocannabinol (THC) and some proteins it might bind to.
As more U.S. states legalize cannabis (also known as marijuana) for medical and recreational use, increasing numbers of people are experimenting with it for pain relief.
Around 17,000 people in the UK are now thought to have received legal medical cannabis for a range of conditions including chronic pain, depression, insomnia and Parkinson’s.
Growing numbers of patients, consuming cannabinoids admitted to surgery, create a challenge to anesthesia providers
Insufficient management of cancer-associated chronic and neuropathic pain adversely affects patient quality of life.
Globally, chronic pain is a major therapeutic challenge and affects more than 15% of the population.
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis.
The purpose of this study was to provide the most up-to-date scientific evidence of the potential analgesic effects, or lack thereof, of the marijuana plant (cannabis) or cannabinoids, and of safety or tolerability of their long-term use.